急性肝衰竭患者血清中B7诱导的T细胞细胞毒性T淋巴细胞相关蛋白4表达增加,降低适应性免疫
研究收集急性肝衰竭(ALF)患者及对照者的外周血单个核细胞,发现ALF患者CD4+ T细胞中CTLA4表达升高且对抗原刺激的增殖反应降低,血清可溶性B7升高,血浆置换可降低可溶性B7及CTLA4表达。
要点
- ALF患者外周血CD4+ CTLA4+ T细胞比例高于对照,合并感染者比例最高。
- ALF患者CD4+ T细胞对 antigen 或CD3刺激的增殖反应降低,抗CTLA4抗体可恢复至对照水平。
- 血浆置换降低ALF患者血清可溶性B7及T细胞CTLA4表达。
核心结论
- ALF患者外周CD4+ T细胞CTLA4表达增加,对 antigen 和CD3刺激反应降低。
- ALF患者血清及对乙酰氨基酚肝损伤小鼠血清可溶性B7浓度升高,上调T细胞CTLA4表达并降低对 antigen 的反应。
- 血浆置换降低ALF患者血清B7水平,可能用于恢复抗菌反应。
研究设计与样本
- 研究收集2013年9月至2015年9月的外周血单个核细胞,包括45例ALF患者、20例慢加急性肝衰竭患者、15例无急性失代偿证据的肝硬化患者、20例无肝硬化或肝病的感染性休克患者和20名健康人。
- 分离循环CD4+ T细胞,用流式细胞术分析,并与 antigen 或CD3激动剂及树突状细胞共孵育,加或不加抗CTLA4抗体,定量T细胞增殖和蛋白表达。
- 检测健康或病变肝组织分离的原代肝细胞、肝窦内皮细胞和胆管上皮细胞上清中可溶性B7水平,以及患者、对照和对乙酰氨基酚诱导肝损伤小鼠血清可溶性B7水平。
主要发现
- ALF患者外周血CD4+ CTLA4+ T细胞比例高于对照,合并感染者比例最高。
- ALF患者CD4+ T细胞对 antigen 或CD3刺激的增殖反应低于对照,加抗CTLA4抗体后增殖反应增至与对照细胞相同水平。
- 对照CD4+ T细胞与ALF患者血清培养24-48小时后CTLA4表达上调,ALF患者血清可溶性B7浓度高于对照血清。
- 对乙酰氨基酚处理的人原代坏死肝细胞分泌高水平可溶性B7,而ALF患者的肝窦内皮细胞和胆管上皮细胞不分泌。
- 对乙酰氨基酚诱导肝损伤小鼠血清可溶性B7水平高于无肝损伤小鼠,血浆置换降低ALF患者循环可溶性B7水平和T细胞CTLA4表达。
临床怎么用
- 作者认为血浆置换降低ALF患者血清B7水平,可能用于恢复抗菌反应。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Patients with acute liver failure (ALF) have defects in innate immune responses to microbes (immune paresis) and are susceptible to sepsis. Cytotoxic T-lymphocyte-associated protein 4 (CTLA4), which interacts with the membrane receptor B7 (also called CD80 and CD86), is a negative regulator of T-cell activation. We collected T cells from patients with ALF and investigated whether inhibitory signals down-regulate adaptive immune responses in patients with ALF. METHODS: We collected peripheral blood mononuclear cells from patients with ALF and controls from September 2013 through September 2015 (45 patients with ALF, 20 patients with acute-on-chronic liver failure, 15 patients with cirrhosis with no evidence of acute decompensation, 20 patients with septic shock but no cirrhosis or liver disease, and 20 healthy individuals). Circulating CD4+ T cells were isolated and analyzed by flow cytometry. CD4+ T cells were incubated with antigen, or agonist to CD3 and dendritic cells, with or without antibody against CTLA4; T-cell proliferation and protein expression were quantified. We measured levels of soluble B7 molecules in supernatants of isolated primary hepatocytes, hepatic sinusoidal endothelial cells, and biliary epithelial cells from healthy or diseased liver tissues. We also measured levels of soluble B7 serum samples from patients and controls, and mice with acetaminophen-induced liver injury using enzyme-linked immunosorbent assays. RESULTS: Peripheral blood samples from patients with ALF had a higher proportion of CD4+ CTLA4+ T cells than controls; patients with infections had the highest proportions. CD4+ T cells from patients with ALF had a reduced proliferative response to antigen or CD3 stimulation compared to cells from controls; incubation of CD4+ T cells from patients with ALF with an antibody against CTLA4 increased their proliferative response to antigen and to CD3 stimulation, to the same levels as cells from controls. CD4+ T cells from controls up-regulated expression of CTLA4 after 24-48 hours culture with sera from patients with ALF; these sera were found to have increased concentrations of soluble B7 compared to sera from controls. Necrotic human primary hepatocytes exposed to acetaminophen, but not hepatic sinusoidal endothelial cells and biliary epithelial cells from patients with ALF, secreted high levels of soluble B7. Sera from mice with acetaminophen-induced liver injury contained high levels of soluble B7 compared to sera from mice without liver injury. Plasma exchange reduced circulating levels of soluble B7 in patients with ALF and expression of CTLA4 on T cells. CONCLUSIONS: Peripheral CD4+ T cells from patients with ALF have increased expression of CTLA4 compared to individuals without ALF; these cells have a reduced response to antigen and CD3 stimulation. We found sera of patients with ALF and from mice with liver injury to have high concentrations of soluble B7, which up-regulates CTLA4 expression by T cells and reduces their response to antigen. Plasma exchange reduces levels of B7 in sera from patients with ALF and might be used to restore antimicrobial responses to patients.
引用
- Khamri W, Abeles RD, Hou TZ, et al. Increased Expression of Cytotoxic T-Lymphocyte-Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute Liver Failure. Gastroenterology. 2017. PMID: 28363639. doi:10.1053/j.gastro.2017.03.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。